Maeva Maurin

Papers

Total Citations

H-Index

About

Maeva Maurin is a radiation oncologist whose work focuses on advancing precision radiotherapy for breast cancer, particularly through the integration of robotic stereotactic techniques. Her most notable contribution is the phase 2 trial "Robotic Stereotactic Boost in Early Breast Cancer," which demonstrated the feasibility and safety of delivering a highly targeted radiation boost to the tumor bed using robotic stereotactic radiosurgery. This study, published in 2018, has garnered 3 citations and represents a critical step in refining dose escalation strategies to improve local control while minimizing toxicity to surrounding healthy tissue. Maurin’s research sits at the intersection of technological innovation and clinical oncology, exploring how robotic platforms can enhance the accuracy of radiation delivery in early-stage disease. Her work contributes to the broader movement toward personalized, hypofractionated regimens that reduce treatment duration and improve patient outcomes. While still early in her career, Maurin’s focus on stereotactic techniques positions her as a contributor to the evolving landscape of breast cancer radiotherapy, where precision and patient-centered care are paramount.